Evidence map›Paper›PMID 36996122›Full record

ArticlePloS one2023

Mpox in Nigeria: Perceptions and knowledge of the disease among critical stakeholders-Global public health consequences.

Olajoju J Awoyomi, Emmanuel O Njoga, Ishmael F Jaja, Felix A Oyeleye, Priscilla O Awoyomi, Musawa A Ibrahim, M A Saulawa, Haruna B Galadima, Adekunle B Rowaiye, Taiwo I Olasoju and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Drivers of zoonoticOne health (Amsterdam, Netherlands) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 2 countries.

Olajoju J AwoyomiDepartment of Veterinary Public Health and Preventive Medicine, College of Veterinary Medicine, Federal University of Agriculture, Abeokuta, Nigeria.
Emmanuel O NjogaDepartment of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.ORCID 0000-0002-2333-7584
Ishmael F JajaDepartment of Agriculture and Animal Health, Florida Campus, University of South Africa, Johannesburg, South Africa.
Felix A OyeleyeDepartment of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.ORCID 0000-0002-9907-3095
Priscilla O AwoyomiDepartment of Medicine and Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Musawa A IbrahimDepartment of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria.
M A SaulawaDepartment of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, Bayero University Kano, Kano State, Nigeria.
Haruna B GaladimaDepartment of Veterinary Medicine, Faculty of Veterinary Medicine, University of Maiduguri, Maiduguri, Nigeria.
Adekunle B RowaiyeDepatment of Agricultural Biotechnology, National Biotechnology Development Agency, Abuja, Nigeria.
Taiwo I OlasojuFederal Ministry of Agriculture and Rural Development, Department of Veterinary and Pest Control Services, Epidemiology Division, Garki, Abuja, Nigeria.
Jamila A IdrisaDepartment of Medicine, College of Medical Sciences, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
Folasade D H OlalereLagos State University College of Medicine/Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Mary I OlasojuDepartment of Veterinary Public Health and Preventive Medicine, College of Veterinary Medicine, Federal University of Agriculture, Abeokuta, Nigeria.
Oluwatosin H AdisaDepartment of Family Medicine, Sacred Heart Hospital, Lantoro, Abeokuta, Nigeria.
Veronica E AdetunjiDepartment of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Osagie O IdemudiaMinistry of Agriculture and Food Safety, Edo State, Nigeria.
Ekene V EzendukaDepartment of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.
James W OguttuDepartment of Agriculture and Animal Health, Florida Campus, University of South Africa, Johannesburg, South Africa.ORCID 0000-0001-6810-4437
University of Nigeria · NGFederal University of Agriculture · NGUniversity of Ibadan · NGUniversity of Maiduguri · NGUniversity of South Africa · ZABayero University Kano · NGFederal Ministry of Agriculture and Rural Development · NGLagos State University Teaching Hospital · NGNational Primary Health Care Development Agency · NGSacred Heart Hospital · NGUsmanu Danfodiyo University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mpox (monkeypox) disease is a re-emerging viral zoonosis of international concern that is endemic in parts of Africa. The mpox virus (MPXV), which was hitherto largely limited to some Central and West African countries, was declared a public health emergency of international concern by the WHO on July 23, 2022 following the rapid spread of the virus to non-endemic countries. Globally, as of March 16, 2023, the WHO had reported 86,496 laboratory-confirmed cases of mpox and 111 deaths in 110 countries. Of the 1,420 cases of mpox reported in Africa as of March 16, 2023, Nigeria alone recorded 57.1% (812) of the confirmed cases and eight fatalities recorded in the continent. To help improve on the understanding of the current situation in Nigeria, the present study assessed the perception and knowledge of mpox among Nigerian healthcare workers, academics and tertiary students. The study also sought to highlight the global public health significance of the MPXV, and recommend a One Health approach to limit exporting of the virus beyond the borders of Nigeria.

methodsA web-based cross-sectional survey was conducted between 24 July 2022 and 12 August 2022 to evaluate the perception and knowledge of mpox among 1544 Nigerians, consisted of healthcare workers (n = 832), academics (n = 306) and tertiary students (n = 462). Data on the respondents' socio demographics and their information sources on mpox were also collected. Each correct response was allotted one point while an incorrect response was scored zero. The scores for perception and knowledge were dichotomized into positive (>5.5) and negative (≤5.5) and adequate (>5.8) and inadequate (≤5.8), respectively; using the average scores for perception and knowledge. The average score for perception and knowledge were summarised and presented as the mean and standard deviation (SD). Chi-square tests of association and binary logistic regression were carried out to determine factors associated with the outcome variables.

resultsOf the 1452 respondents that had heard of mpox, 878 (60.5%) and 419 (28.9%) had adequate knowledge and positive perception concerning MPXV infection respectively. Average perception score was 5.5. Mean perception and knowledge scores were 4.5(SD: 2.0) and 5.8 (SD: 1.9), respectively. Factors that were significantly associated with knowledge level were age (p = 0.020) educational qualification attained (p = 0.004), occupation (p<0.001), and geopolitical zone of residency (p = 0.001). There was a positive correlation between perception and knowledge scores (r = 0.4, p<0.001). Positive perceptions were likely among respondents who had tertiary education, and residing in North-west Nigeria. Likewise, adequate knowledge scores were likely among respondents under 30 years of age, with tertiary education or reside in North-west Nigeria. Sources of information were significantly associated with perception (p = 0.004) and knowledge (p<0.001) of the respondents.

conclusionThe findings of this study show that there is disparity in the knowledge and perception of mpox in the study population, and as a result, there is a need to intensify awareness about MPXV infection to enhance positive perception among the respondents. This has potential to safeguard public health and contain the disease thus preventing it from spreading to the global community. A One Health approach involving animal and human health workers is imperative for improved knowledge and a good perception towards the disease among respondents, and enhanced active surveillance and early detection of MPXV in reservoir hosts (rodents and non-human primates); to prevent reverse zoonotic transmission of the virus at the human-animal interface.

Indexed as

Mpox, MonkeypoxPublic HealthCross-Sectional StudiesHumansNigeriaSurveys and Questionnaires

Identifiers

PMID36996122
PMCPMC10062623
OpenAlexW4361266938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.